You are here

  • Home
  • Archive
  • Volume 25, Issue 2
  • Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitors

Article metrics

Article menu

Download PDFPDF

EBM verdict
General medicine
Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitors
Free

 

Online download statistics by month:

Online download statistics by month: July 2019 to March 2024

AbstractFullPdf
Jul 20196920
Aug 201912209251
Sep 20197915422
Oct 2019318269
Nov 2019207188
Dec 2019152124
Jan 2020178169
Feb 202016581
Mar 202028116738
Apr 202019217571
May 202012411338
Jun 2020524521
Jul 2020767325
Aug 2020625929
Sep 2020584914
Oct 2020827522
Nov 2020575127
Dec 2020525115
Jan 2021474313
Feb 2021575617
Mar 2021575523
Apr 2021413710
May 202125259
Jun 2021696921
Jul 202133337
Aug 2021363614
Sep 2021343410
Oct 2021525126
Nov 2021444421
Dec 2021515335
Jan 2022546113
Feb 2022454821
Mar 2022444314
Apr 2022454512
May 2022413719
Jun 2022656334
Jul 202249515
Aug 202269607
Sep 2022575724
Oct 202246473
Nov 2022545115
Dec 202238397
Jan 202340336
Feb 202354604
Mar 202316155
Apr 202313123
May 202328289
Jun 2023869744
Jul 2023211814
Aug 202314134
Sep 202314130
Oct 202327253
Nov 202323235
Dec 20231493
Jan 202415122
Feb 202420204
Mar 20244535171
Total571926371061